Sensei Biotherapeutics, Inc.
Regulated industryPhysical productsSells to businessesDevelopment stageTags from an AI model reading the company description.
Key Metrics
- Previous Close
- —
- 52-Week Range
- —
- Market Cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Dividend Yield
- —
Advanced Metrics
- Price/Book
- —
- PEG Ratio
- —
- Return on Equity
- —
- Return on Assets
- —
- Gross Margin
- —
- Operating Margin
- —
- Profit Margin
- —
- Current Ratio
- —
- Debt/Equity
- —
- Total Debt
- —
- Free Cash Flow
- —
- Revenue Growth
- —
- Earnings Growth
- —
- Enterprise Value
- —
Market Snapshot
About
Sensei Biotherapeutics is a clinical-stage immunotherapy company developing next-generation therapeutics for cancer treatment. The company focuses on innate immunity to develop conditionally-activated immunotherapies designed to overcome tumor resistance mechanisms. Sensei is advancing multiple programs targeting both solid tumors and hematologic malignancies.